Caffeine as Respiratory Stimulant in Preterm Infants

• Status: Unknown status
• Trial end date: 2020-11-01
• Target enrollment: 0
• Participant gender: All

Summary

comparison between rate of occurance of apnea of prematurity AOP when using high and low dose caffeine

• Phase: Phase 1
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Ain Shams University
• Treatments: Caffeine; Caffeine citrate; Central Nervous System Stimulants; Respiratory System Agents

Criteria

Inclusion Criteria:

• • Preterm infants with a gestational age <32 weeks in room air or CPAP (prophylactic).

• Preterm infants with gestational age 32-34 weeks who exhibited apnea of prematurity within the first 10 days of life in room air or CPAP

Exclusion Criteria:

• • Major congenital malformations.

• Chromosomal anomalies.

• Preterm infants on mechanical ventilation.

• Preterm infants on NIPPV.